Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

Although there is one GLP-1 medication, Rybelsus, currently given as a daily pill, it has so far only been prescribed as a treatment for diabetes, not weight loss. All GLP-1s approved for weight loss ...

A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar ...

A daily pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth ...

A new proposed law designed to restrict a minor’s access to certain dietary supplements. Meanwhile, FOX 2 was contacted by ...

Each year, millions of people turn to diet pills to lose weight. As of 2022, about 15 percent of U.S. adults reported using a weight-loss supplement at some point in their lives. One popular ...

Oral weight-loss pills will be replacing GLP-1 shots by March 2026, Medicare and Medicaid Services Administrator Dr. Mehmet Oz predicted on Monday. Oz made the statement during a Monday morning ...

WASHINGTON — Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's new national priority voucher, suggesting it is a strong ...

Eli Lilly (NYSE:LLY) has already manufactured billions of doses of its next-generation weight-loss pill, anticipating strong global demand ahead of a potential launch next year. “We’ve already made, ...

Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch next year. “We’ve already made, actually, ...